Johnson & Johnson : advances leadership in oncology innovation with more than 75 clinical study and real-world presentations at ASCO and EHA
Media contacts: Investor contact: ...
Stay updated with breaking news from Solid Tumor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Media contacts: Investor contact: ...
People with cancer may encounter checkpoint inhibitors as a treatment option but may not know where to start. This article can help you learn more.
Faculty position, Department of Oncology – Solid Tumor Division job in Memphis, Tennessee with St. Jude Children's Research Hospital (St. Jude). Apply Today.
Here are department closures or services ending, announced, advanced or finalized that Becker's has reported since Jan. 19:
Sacituzumab govitecan and pembrolizumab can produce a high response rate in previously treated, advanced urothelial carcinoma, according to researchers. Sacituzumab govitecan and pembrolizumab can produce a high response rate in previously treated, advanced urothelial carcinoma, according to researchers.